Ventas CEO Debra Cafaro sells $3.17 million in shares

Published 07/04/2025, 23:58
Ventas CEO Debra Cafaro sells $3.17 million in shares

Debra A. Cafaro, Chairman and CEO of Ventas, Inc. (NYSE:VTR), recently executed a series of stock transactions, according to a filing with the Securities and Exchange Commission. On April 3, Cafaro sold shares worth approximately $3.17 million. The shares were sold at prices ranging from $71.0592 to $71.0639 per share. The transaction comes as Ventas, currently valued at $28.23 billion, has delivered an impressive 53.5% return over the past year. According to InvestingPro analysis, the company's financial health is rated as GOOD, though the stock appears to be trading at premium valuations.

These transactions were part of a pre-arranged trading plan under Rule 10b5-1, which Cafaro entered into on March 28, 2024. The transactions also included the exercise of stock options, totaling $2.79 million, at prices between $62.22 and $65.45. Following these transactions, Cafaro holds 1,145,695 shares of Ventas common stock, demonstrating continued confidence in the company's prospects.

Ventas, Inc., a real estate investment trust based in Chicago, Illinois, has maintained dividend payments for 27 consecutive years, currently offering a yield of 3%. The company's comprehensive analysis, including 10 key ProTips and detailed valuation metrics, is available through InvestingPro's exclusive research reports.

In other recent news, Ventas has been the subject of multiple analyst updates following its recent earnings results. Citi has increased its price target for Ventas to $80, maintaining a Buy rating. This revision is based on an updated valuation model, which now estimates higher core funds from operations for 2025 and 2026. RBC Capital Markets also raised its price target to $74 while keeping an Outperform rating, citing Ventas' strategic investments in the seniors housing sector as a positive growth driver.

Baird upgraded Ventas from Neutral to Outperform, despite a slight reduction in the price target to $65, due to the company's improved leverage and access to capital markets. BMO Capital Markets highlighted Ventas as one of the least at-risk REITs from potential changes in Federal Medical (TASE:BLWV) Assistance Percentages funding. Additionally, Ventas plans to divest a portion of its skilled nursing facilities in Pennsylvania, which may mitigate some financial risks. Collectively, these developments reflect a positive outlook from analysts on Ventas' strategic positioning and financial health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.